Clinical trial
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone…
NCT00061087 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00061087 |
|---|---|
| Title | Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 |
| Official title | Treatment of Adult ADHD in Methadone Patients |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | ADHD, Opioid-Related Disorders, Cocaine Dependence |
| Intervention type | Drug, Other |
| Interventions | Methylphenidate, Bupropion, Placebo |
| Enrollment | 115 |
| Start date | Feb 1, 1998 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | May 22, 2003 |
| Last update posted | Apr 23, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: